NCT00000313

Brief Summary

The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 21, 1999

Completed
Last Updated

January 12, 2017

Status Verified

December 1, 2002

First QC Date

September 20, 1999

Last Update Submit

January 11, 2017

Conditions

Keywords

cocaine dependence

Outcome Measures

Primary Outcomes (4)

  • Side effects

  • Neuroendocrine changes

  • Psychological changes

  • Craving

Interventions

Eligibility Criteria

Age25 Years - 50 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Please contact site for information.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

VA Medical Center

Brooklyn, New York, 11209, United States

Location

MeSH Terms

Conditions

Cocaine-Related Disorders

Interventions

Fenfluramine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenethylaminesEthylaminesAminesOrganic Chemicals

Study Officials

  • Laure Buydens-Branchey, M.D.

    VA Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

September 20, 1999

First Posted

September 21, 1999

Last Updated

January 12, 2017

Record last verified: 2002-12

Locations